Nasal drug delivery apparatus and methods of use
A nasal droplet delivery device and related methods for delivering precise and repeatable dosages to a subject via the nasal passageways and sinus cavities.
1. An automatically actuated nasal droplet delivery device for delivering a fluid as an ejected stream of droplets to the nasal passageways and sinus cavities of a subject, the device comprising:
a housing;
a nosepiece positioned at an airflow exit of the device;
a reservoir disposed within or in fluid communication with the housing for receiving a volume of fluid;
an electronically actuated ejector mechanism in fluid communication with the reservoir and configured to generate the ejected stream of droplets;
at least one differential pressure sensor positioned within the housing, the at least one differential pressure sensor configured to activate the ejector mechanism upon sensing a pre-determined pressure change within the device to thereby generate the ejected stream of droplets;
the ejector mechanism comprising an oscillation actuator and an aperture plate, the aperture plate having a plurality of openings formed through its thickness and the actuator operable to oscillate the aperture plate at a frequency to thereby generate the ejected stream of droplets; and
a photodetector configured to measure an ejected dose of medicament in the ejected stream of droplets.
2. The droplet delivery device of claim 1 , wherein the housing and ejector mechanism are oriented such that an exit side of the aperture plate is perpendicular to the direction of airflow and the stream of droplets is ejected in parallel to the direction of airflow.
3. The droplet delivery device of claim 1 , wherein the housing and ejector mechanism are oriented such that an exit side of the aperture plate is parallel to the direction of airflow and the stream of droplets is ejected substantially perpendicularly to the direction of airflow such that the ejected stream of droplets is directed through the housing at an approximate 90 degree change of trajectory prior to expulsion from the housing.
4. The droplet delivery device of claim 1 , wherein the aperture plate comprises a domed shape.
5. The droplet delivery device of claim 1 , wherein the aperture plate is composed of a material selected from the group consisting of poly ether ether ketone (PEEK), polyimide, polyetherimide, polyvinylidine fluoride (PVDF), ultra-high molecular weight polyethylene (UHMWPE), nickel, nickel-cobalt, nickel-palladium, palladium, platinum, metal alloys thereof, and combinations thereof.
6. The droplet delivery device of claim 1 , wherein one or more of the plurality of openings have different cross-sectional shapes or diameters to thereby provide ejected droplets having different average ejected droplet diameters.
7. The droplet delivery device of claim 1 , wherein the nosepiece is removably coupled with the device.
8. The droplet delivery device of claim 1 , wherein the reservoir is removably coupled with the housing.
9. The droplet delivery device of claim 1 , wherein the reservoir is coupled to the ejector mechanism to form a combination reservoir/ejector mechanism module, and the combination reservoir/ejector mechanism module is removably coupled with the housing.
10. The droplet delivery device of claim 1 , further comprising a wireless communication module.
11. A method for delivering a therapeutic agent as an ejected stream of droplets to the nasal passageways and sinus cavities of a subject for the treatment of a disease, disorder or condition, the method comprising:
(a) generating an ejected stream of droplets via a droplet delivery device of claim 1 ; and
(b) delivering the ejected stream of droplets to the nasal passageways and sinus cavities of the subject such that at least about 50% of the mass of the ejected stream of droplets is delivered into the nasal passageways and sinus cavities of the subject during use to thereby treat the disease, disorder or condition.
12. The method of claim 11 , wherein the disease, disorder, or condition is a local nasal or sinus disease, disorder or condition.
13. The method of claim 11 , wherein the disease, disorder, or condition is a system disease, disorder or condition.
14. The method of claim 11 , further comprising proving feedback from the device of whether a dose is successfully administered.
15. The method of claim 11 , further comprising measuring entrained droplet velocity of droplets in the ejected stream.
16. The device of claim 1 , further comprising a sensor configured to measure entrained droplet velocity of droplets in the ejected stream.
17. The device of claim 2 , further comprising a sensor configured to measure entrained droplet velocity of droplets in the ejected stream.
18. The device of claim 3 , further comprising a sensor configured to measure entrained droplet velocity of droplets in the ejected stream.
19. The device of claim 6 , further comprising a sensor configured to measure entrained droplet velocity of droplets in the ejected stream.
20. The device of claim 10 , further comprising a sensor configured to measure entrained droplet velocity of droplets in the ejected stream.